Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsReceivables - NetShares Repurchased
Ratios

Tg Therapeutics (TGTX) Receivables - Other (2016 - 2024)

Tg Therapeutics has reported Receivables - Other over the past 5 years, most recently at $23.5 million for Q4 2024.

  • Quarterly results put Receivables - Other at $23.5 million for Q4 2024, up 298.31% from a year ago — trailing twelve months through Dec 2024 was $23.5 million (up 298.31% YoY), and the annual figure for FY2024 was $23.5 million, up 298.31%.
  • Receivables - Other for Q4 2024 was $23.5 million at Tg Therapeutics, up from $6.5 million in the prior quarter.
  • Over the last five years, Receivables - Other for TGTX hit a ceiling of $23.5 million in Q4 2024 and a floor of $5.9 million in Q4 2023.